Home Clinical indications for plasma protein assays: transthyretin (prealbumin) in inflammation and malnutrition: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC): IFCC Scientific Division Committee on Plasma Proteins (C-PP)
Article
Licensed
Unlicensed Requires Authentication

Clinical indications for plasma protein assays: transthyretin (prealbumin) in inflammation and malnutrition: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC): IFCC Scientific Division Committee on Plasma Proteins (C-PP)

  • A. Myron Johnson , Giampaolo Merlini , Joanna Sheldon and Kiyoshi Ichihara
Published/Copyright: March 22, 2007
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 45 Issue 3

Abstract

A large number of circumstances are associated with reduced serum concentrations of transthyretin (TTR), or prealbumin. The most common of these is the acute phase response, which may be due to inflammation, malignancy, trauma, or many other disorders. Some studies have shown a decrease in hospital stay with nutritional therapy based on TTR concentrations, but many recent studies have shown that concentrations of albumin, transferrin, and transthyretin correlate with severity of the underlying disease rather than with anthropometric indicators of hypo- or malnutrition.

There are few if any conditions in which the concentration of this protein by itself is more helpful in diagnosis, prognosis, or follow up than are other clinical findings. In the majority of cases, the serum concentration of C-reactive protein is adequate for detection and monitoring of acute phase responses and for prognosis. Although over diagnosis and treatment of presumed protein energy malnutrition is probably not detrimental to most patients, the failure to detect other causes of decreased concentrations (such as serious bacterial infections or malignancy) of the so-called visceral or hepatic proteins could possibly result in increased morbidity or even mortality. In addition to these caveats, assays for TTR have a relatively high level of uncertainty (“imprecision”). Clinical evaluation – history and physical examination – should remain the mainstay of nutritional assessment.

Clin Chem Lab Med 2007;45:419–26.

:

Corresponding author: Andrew Myron Johnson, MD, 610 Bruton Place South, Greensboro, NC 27410-4660, USA Phone: +1-336-292-2072; Fax: +1-919-966-1999,

References

1. Fuhrman MP, Charney P, Mueller CM. Hepatic proteins and nutrition assessment. J Am Diet Assoc2004;104:1258–64.10.1016/j.jada.2004.05.213Search in Google Scholar PubMed

2. Johnson AM. Low levels of plasma proteins: malnutrition or inflammation? Clin Chem Lab Med1999;37:91–6.10.1515/CCLM.1999.017Search in Google Scholar PubMed

3. Shenkin A. Assessment of nutritional status – implications for nutritional support and hospitalization. Plasma Protein Monitor2005;1:9–11.Search in Google Scholar

4. Mears E. Nutritional assessment. An opportunity for laboratorians to improve health care. Clin Lab News2005;June:12–6.Search in Google Scholar

5. Brugler L, Stankovic A, Bernstein L, Scott F, O'Sullivan-Maillet J. The role of visceral protein markers in protein calorie malnutrition. Clin Chem Lab Med2002;40:1360–9.10.1515/CCLM.2002.235Search in Google Scholar PubMed

6. Ingenbleek Y, Young V. Transthyretin (prealbumin) in health and disease: nutritional implications. Annu Rev Nutr1994;14:495–533.10.1146/annurev.nu.14.070194.002431Search in Google Scholar PubMed

7. Gidden F, Shenkin A. Laboratory support of the clinical nutrition service. Clin Chem Lab Med2000;38:693–714.10.1515/CCLM.2000.100Search in Google Scholar PubMed

8. Pencharz PB, Azcue M. Use of bioelectrical impedance analysis measurements in the clinical management of malnutrition. Am J Clin Nutr1996;64(Suppl):485S–8S.10.1093/ajcn/64.3.485SSearch in Google Scholar PubMed

9. Yeh SS, Hafner A, Chang CK, Levine DM, Parker TS, Schuster MW. Risk factors relating blood markers of inflammation and nutritional status to survival in cachectic geriatric patients in a randomized clinical trial. J Am Geriatr Soc2004;52:1708–12.10.1111/j.1532-5415.2004.52465.xSearch in Google Scholar PubMed

10. Yovita H, Djumhana A, Abdurachman SA, Saketi JR. Correlation between anthropometric measurements, prealbumin level and transferrin serum with Child-Pugh classification in evaluating nutritional status of liver cirrhosis. Acta Med Indones2004;35:197–201.Search in Google Scholar

11. Koretz RL. Nutrition Society Symposium on “End points in clinical nutrition trials.” Death, morbidity and economics are the only end points for trials. Proc Nutr Soc2005;64:277–84.10.1079/PNS2005433Search in Google Scholar

12. Cano NJ, Pichard C, Roth H, Court-Fortune I, Cynober L, Gerard-Boncompain M, et al. C-reactive protein and body mass index predict outcome in end-stage respiratory failure. Chest2004;126:540–6.10.1378/chest.126.2.540Search in Google Scholar PubMed

13. Ingbar SH. Pre-albumin: a thyroxin binding protein of human plasma. Endocrinology1958;63:256–9.10.1210/endo-63-2-256Search in Google Scholar PubMed

14. Rask L, Anundi H, Peterson PA. The primary structure of the human retinol-binding protein. FEBS Lett1979;104:55–8.10.1016/0014-5793(79)81084-4Search in Google Scholar

15. Schultze HE, Heremans JF. Molecular biology of human proteins. London: Elsevier, 1966:476–7.Search in Google Scholar

16. Schultze HE, Schönenberger M, Schwick G. Über ein Präalbumin des menschlichen Serums. Biochem Z1956;328:267–84.Search in Google Scholar

17. Goodman DS, Peters T, Robbins J, Schwick G. Prealbumin becomes transthyretin. J Biol Chem1981;256:12–4.Search in Google Scholar

18. Monaco HL. The transthyretin-retinol-binding protein complex. Biochim Biophys Acta2000;1482:65–72.10.1016/S0167-4838(00)00140-0Search in Google Scholar

19. Noy N, Slosberg E, Scarlata S. Interactions of retinol with binding proteins: studies with retinol binding protein and with transthyretin. Biochemistry1992;31:11118–24.10.1021/bi00160a023Search in Google Scholar

20. Gitlin D, Pericelli A. Synthesis of serum albumin, prealbumin, alpha-fetoprotein, alpha-1-antitrypsin and transferrin by the human yolk sac. Nature1970;228:995–7.10.1038/228995a0Search in Google Scholar

21. Bienvenu J, Jeppsson J-O, Ingenbleek Y. Transthyretin (prealbumin) and retinol binding protein. In: Ritchie RF, Navolotskaia O, editors. Serum proteins in clinical medicine, vol. 1. Laboratory section. Scarborough, ME: Foundation for Blood Research, 1995:9.01.01–9.01.07.Search in Google Scholar

22. Jacobsson B. In situ localization of transthyretin-mRNA in the adult human liver, choroid plexus and pancreatic islets and in endocrine tumours of the pancreas and gut. Histochemistry1989;91:299–304.10.1007/BF00493004Search in Google Scholar

23. Ong DE, Davis JT, O'Day WT, Bok D. Synthesis and secretion of retinol-binding protein and transthyretin by cultured retinal pigment epithelium. Biochemistry1994;33:1835–42.10.1021/bi00173a029Search in Google Scholar

24. Oppenheimer JH, Surks MI, Bernstein G, Smith JC. Metabolism of iodine 131-labeled thyroxin-binding prealbumin in man. Science1965;149:748–51.10.1126/science.149.3685.748Search in Google Scholar

25. Socolow EL, Woeber KA, Purdy RH, Holloway MT, Ingbar SH. Preparation of I131-labeled human serum prealbumin and its metabolism in normal and sick patients. J Clin Invest1965;44:1600–9.10.1172/JCI105266Search in Google Scholar

26. Wallace MR, Naylor S, Kluve-Beckerman B, Long GL, McDonald L. Localization of the human prealbumin gene to chromosome 18. Biochem Biophys Res Commun1985;129:753–8.10.1016/0006-291X(85)91956-4Search in Google Scholar

27. Costa PP, Figueira A, Bravo F. Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc Natl Acad Sci USA1978;75:4449–503.10.1073/pnas.75.9.4499Search in Google Scholar PubMed PubMed Central

28. Nordlie M, Sletten K, Husby G, Ranlov PJ. A new prealbumin variant in familial cardiomyopathy of Danish origin. Scand J Immunol1988;27:119–22.10.1111/j.1365-3083.1988.tb02329.xSearch in Google Scholar

29. Merlini G, Westermark P. The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies [review]. J Intern Med2004;255:159–78.10.1046/j.1365-2796.2003.01262.xSearch in Google Scholar

30. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal1999;13:273–9.10.1002/(SICI)1098-2825(1999)13:6<273::AID-JCLA4>3.0.CO;2-XSearch in Google Scholar

31. McClave SA, Mitoraj TE, Thielmeier KA, Greenburg RA. Differentiating subtypes (hypoalbuminemic vs marasmic) of protein-calorie malnutrition: incidence and clinical significance in a university hospital setting. J Parenter Enteral Nutr1992;16:337–42.10.1177/0148607192016004337Search in Google Scholar

32. Manary MJ, Broadhead RL, Yarasheski KE. Whole-body protein kinetics in marasmus and kwashiorkor during acute infection. Am J Clin Nutr1998;67:1205–9.10.1093/ajcn/67.6.1205Search in Google Scholar

33. Iputo JE. Protein-losing enteropathy in Transkeian children with morbid protein-energy malnutrition. S Afr Med J1993;83:588–9.Search in Google Scholar

34. Peters T Jr. Serum albumin. Adv Protein Chem1985;37:161–245.10.1016/S0065-3233(08)60065-0Search in Google Scholar

35. Ingenbleek Y, De Visscher M, De Nayer P. Measurement of prealbumin as index of protein-calorie malnutrition. Lancet1972;2:106–9.10.1016/S0140-6736(72)91596-6Search in Google Scholar

36. Thurnham DI, McCabe GP, Northrop-Clewes CA, Nestel P. Effects of subclinical infection on plasma retinol concentrations and assessment of prevalence of vitamin A deficiency: meta-analysis. Lancet2003;362:2052–8.10.1016/S0140-6736(03)15099-4Search in Google Scholar

37. Vellas B, Guigoz Y, Baumgartner M, Garry PJ, Lauque S, Albarede J-L. Relationships between nutritional markers and the mini-nutritional assessment in 155 older persons. J Am Geriatr Soc2000;48:1300–9.10.1111/j.1532-5415.2000.tb02605.xSearch in Google Scholar

38. Raynaud-Simon A, Lafont S, Berr C, Dartigues JF, Baulieu EE, Le Bouc Y. Plasma insulin-like growth factor I levels in the elderly: relation to plasma dehydroepiandrosterone sulfate levels, nutritional status, health and mortality. Gerontology2001;47:198–206.10.1159/000052799Search in Google Scholar

39. Whicher JT. Acute phase proteins: diagnostic significance and clinical use. AACC Endo1993;11:273–80.Search in Google Scholar

40. Banks RE, Forbes MA, Storr M, Higginson J, Thompson D, Raynes J, et al. The acute phase protein response in patients receiving subcutaneous IL-6. Clin Exp Immunol1995;102:217–23.10.1111/j.1365-2249.1995.tb06659.xSearch in Google Scholar

41. Clark MA, Hentzen BT, Plank LD, Hill GI. Sequential changes in insulin-like growth factor 1, plasma proteins, and total body protein in severe sepsis and multiple injury. J Parenter Enteral Nutr1996;20:363–70.10.1177/0148607196020005363Search in Google Scholar

42. Spies M, Wolf SE, Barrow RE, Jeschke MG, Herndon DN. Modulation of types I and II acute phase reactants with insulin-like growth factor-1/binding protein-3 complex in severely burned children. Crit Care Med2002;30:83–98.10.1097/00003246-200201000-00013Search in Google Scholar

43. Pepersack T. Outcomes of continuous process improvement of nutritional care program among geriatric units. J Gerontol A Biol Sci Med Sci2005;60:787–92.10.1093/gerona/60.6.787Search in Google Scholar

44. Reimund JM, Arondel Y, Escalin G, Finck G, Baumann R, Duclos B. Immune activation and nutritional status in adult Crohn's disease patients. Dig Liver Dis2005;37:424–31.10.1016/j.dld.2005.01.010Search in Google Scholar

45. Ferard G, Gaudias J, Bourguignat A, Ingenbleek Y. C-reactive protein to transthyretin ratio for the early diagnosis and follow-up of postoperative infection. Clin Chem Lab Med2002;40:1334–8.10.1515/CCLM.2002.230Search in Google Scholar

46. Ingenbleek Y, Carpentier YA. A prognostic inflammatory and nutritional index scoring critically ill patients. Int J Vitam Nutr Res1985;55:91–101.Search in Google Scholar

47. Bellinghieri G, Santoro D, Calvani M, Savica V. Role of carnitine in modulating acute-phase protein synthesis in hemodialysis patients. J Renal Nutr2005;15:13–7.10.1053/j.jrn.2004.09.008Search in Google Scholar

48. Thompson D, Whicher JT, Banks RE. Acute phase proteins in predicting disease outcome. Baillières Clin Rheumatol1992;6:393–404.10.1016/S0950-3579(05)80181-5Search in Google Scholar

49. Kaysen GA. Effects of inflammation on plasma composition and endothelial structure and function. J Renal Nutr2005;15:94–8.10.1053/j.jrn.2004.09.021Search in Google Scholar PubMed

50. Rannevik G, Carstrom K, Doeberl A, Laurell C-B. Plasma protein changes induced by two orally administered androgen derivatives. Scand J Clin Lab Invest1996;56:161–6.10.3109/00365519609088603Search in Google Scholar PubMed

51. Barbe P, Bennet A, Stebenet M, Perret B, Louvet JP. Sex-hormone-binding globulin and protein-energy malnutrition indexes as indicators of nutritional status in women with anorexia nervosa. Am J Clin Nutr1993;57:319–22.10.1093/ajcn/57.3.319Search in Google Scholar

52. Nova E, Lopez-Vidriero I, Varela P, Toro O, Casas JJ, Marcos AA. Indicators of nutritional status in restricting-type anorexia nervosa patients: a 1-year follow-up study. Clin Nutr2004;23:1353–9.10.1016/j.clnu.2004.05.004Search in Google Scholar

53. Raguso CA, Genton L, Dupertuis YM, Pichard C. Assessment of nutritional status in organ transplant: is transthyretin a reliable indicator? Clin Chem Lab Med2002;40:1325–8.10.1515/CCLM.2002.228Search in Google Scholar

54. Smale BF, Mullen JL, Hobbs CL, Buzby GP, Rosato EF. Serum protein response to acute dietary manipulation. J Surg Res1980;28:379–88.10.1016/0022-4804(80)90099-2Search in Google Scholar

55. Smale BF, Hobbs CL, Mullen JL, Rosato EF. Serum protein response to surgery and starvation. J Parenter Enteral Nutr1982;6:395–8.10.1177/0148607182006005395Search in Google Scholar

56. Van Wymelbeke V, Guedon A, Maniere D, Manckoundia P, Pfitzenmeyer P. A 6-month follow-up of nutritional status in institutionalized patients with Alzheimer's disease. J Nutr Health Aging2004;8:505–8.Search in Google Scholar

57. Goodman DS. Plasma retinol-binding protein. In: Sporn MB, Roberts AB, Goodman DS, editors. The retinoids, vol. 2. New York: Academic Press, 1984:41–88.Search in Google Scholar

58. Kopple JD, Mehrotra R, Suppasyndh O, Kalantar-Zadeh K. Observations with regard to the National Kidney Foundation K/DOQI clinical practice guidelines concerning serum transthyretin in chronic renal failure. Clin Chem Lab Med2002;40:1308–12.10.1515/CCLM.2002.225Search in Google Scholar

59. Scarpioni L, Dall'Agio PP, Poisetti PG, Buzio C. Retinol binding protein in serum and urine of glomerular and tubular nephropathies. Clin Chim Acta1976;68:107–13.10.1016/0009-8981(76)90409-5Search in Google Scholar

60. Visvardis G, Griveas I, Fleva A, Giannakou A, Papadopoulou D, Mitsopoulos E, et al. Relevance of procalcitonin levels in comparison to other markers of inflammation in hemodialysis patients. Renal Fail2005;27:429–34.10.1081/JDI-200065200Search in Google Scholar

61. Gower T. Nutritional screening tools for CAPD patients: are computers the way forward? EDTNA ERCA J2001;27:197–200.10.1111/j.1755-6686.2001.tb00178.xSearch in Google Scholar PubMed

62. Kaysen GA, Kumar V. Inflammation in ESRD: causes and potential consequences. J Renal Nutr2003;13:158–60.10.1053/jren.2003.50021Search in Google Scholar PubMed

63. Gerard G, Gaudias J, Bourguignat A, Ingenbleek Y. C-reactive protein to transthyretin ratio for the early diagnosis and follow-up of postoperative infection. Clin Chem Lab Med2002;40:1334–8.10.1515/CCLM.2002.230Search in Google Scholar PubMed

64. Lim SH, Lee JS, Chae SH, Ahn BS, Chang DJ, Shin CS. Prealbumin is not sensitive indicator of nutrition and prognosis in critical ill patients. Yonsei Med J2005;46:21–6.10.3349/ymj.2005.46.1.21Search in Google Scholar PubMed PubMed Central

65. Sullivan DH, Bopp MM, Roberson PK. Protein-energy undernutrition and life-threatening complications among the hospitalized elderly. J Gen Intern Med2002;17:923–32.10.1046/j.1525-1497.2002.10930.xSearch in Google Scholar PubMed PubMed Central

66. Pascal N, Amouzou EK, Sanni A, Namour F, Abdelmouttaleb I, Vidailhet M, et al. Serum concentrations of sex hormone binding globulin are elevated in kwashiorkor and anorexia nervosa but not in marasmus. Am J Clin Nutr2002;76:239–44.10.1093/ajcn/76.1.239Search in Google Scholar PubMed

67. Sandstedt S, Cederblad G, Larsson J, Schildt B, Symreng T. Influence of total parenteral nutrition on plasma fibronectin in malnourished subjects with or without inflammatory response. J Parenter Enteral Nutr1984;8:493–6.10.1177/0148607184008005493Search in Google Scholar PubMed

68. Fieber SS. Pseudocholinesterase – a clinical assessment. Crit Care Med1981;9:660–1.10.1097/00003246-198109000-00011Search in Google Scholar PubMed

69. Crowe PJ, Snyman AM, Dent DM, Bunn AE. Assessing malnutrition in gastric carcinoma: bioelectrical impedance or clinical impression? Aust NZ J Surg1992;62:390–3.10.1111/j.1445-2197.1992.tb07209.xSearch in Google Scholar PubMed

70. Baudner S, Bienvenu J, Blirup-Jensen S, Carlström A, Johnson AM, Ward AM, et al. The certification of a matrix reference material for immunochemical measurement of 14 human serum proteins. Publication 92/92. Brussels: BCR, 1992.Search in Google Scholar

71. Blirup-Jensen S, Johnson AM, Larsen M. Protein standardization IV: value transfer procedure for the assignment of serum protein values from a reference preparation to a target material. Clin Chem Lab Med2001;38:1110–22.10.1515/CCLM.2001.176Search in Google Scholar PubMed

Published Online: 2007-03-22
Published in Print: 2007-03-01

©2007 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. From human genetic variations to prediction of risks and responses to drugs and the environment
  2. Nutrigenomics – 2006 update
  3. How to comprehensively analyse proteins and how this influences nutritional research
  4. Genotypes, obesity and type 2 diabetes – can genetic information motivate weight loss? A review
  5. The Gene-Diet Attica Investigation on childhood obesity (GENDAI): overview of the study design
  6. Polymorphisms in the APOA1/C3/A4/A5 gene cluster and cholesterol responsiveness to dietary change
  7. Nutri-epigenomics: lifelong remodelling of our epigenomes by nutritional and metabolic factors and beyond
  8. Emerging role of cathepsin S in obesity and its associated diseases
  9. Association analysis of hepatitis virus B infection with haplotypes of the TBX21 gene promoter region in the Chinese population
  10. Multiplex polymerase chain reaction on FTA cards vs. flow cytometry for B-lymphocyte clonality
  11. Real-time multiplex PCR assay for genotyping of three apolipoprotein E alleles and two choline acetyltransferase alleles with three hybridization probes
  12. Immunomagnetic CD45 depletion does not improve cytokeratin 20 RT-PCR in colorectal cancer
  13. Analysis of the components of hypertransaminasemia after liver resection
  14. Fine characterization of mitral valve glycosaminoglycans and their modification with degenerative disease
  15. Oxidative stress evaluated using an automated method for hydroperoxide estimation in patients with coronary artery disease
  16. Secretory phospholipase A2 activity and release kinetics of vascular tissue remodelling biomarkers after coronary artery bypass grafting with and without cardiopulmonary bypass
  17. Clustered components of the metabolic syndrome and platelet counts in Japanese females
  18. International Standard for serum vitamin B12 and serum folate: international collaborative study to evaluate a batch of lyophilised serum for B12 and folate content
  19. Multicentre physiological reference intervals for serum concentrations of immunoglobulins A, G and M, complement C3c and C4 measured with Tina-Quant® reagents systems
  20. In vivo and in vitro allergy diagnostics: it's time to reappraise the costs
  21. Experience with post-market surveillance of in-vitro diagnostic medical devices for lay use in Germany
  22. Evaluation of the high-sensitivity, full-range Olympus CRP OSR6199 application on the Olympus AU640®
  23. How to improve the teaching of urine microscopy
  24. In vitro determination of allergen-specific serum IgE. Comparative analysis of three methods
  25. Efficacy of a new blocker against anti-ruthenium antibody interference in the Elecsys free triiodothyronine assay
  26. Clinical indications for plasma protein assays: transthyretin (prealbumin) in inflammation and malnutrition: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC): IFCC Scientific Division Committee on Plasma Proteins (C-PP)
  27. Meeting Report: From human genetic variations to prediction of risks and responses to drugs and the environment
Downloaded on 7.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.051/html
Scroll to top button